4 Patents
- US120901472024Combination Therapy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
Celgene Corporation
0 cites - US120611832024Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Poorly Water Soluble Drug
Abraxis Bioscience, LLC
0 cites - US120534662024Antiproliferative Compounds and Bispecific Antibody Against BCMA and CD3 for Combined Use
Celgene Corporation
0 cites - 0 cites